Innovent Dosed First Participant in Phase 3 Clinical Study (GLORY-2) of Mazdutide (IBI362) Higher Dose 9 mg in Chinese Adults with Obesity

Innovent Dosed First Participant in Phase 3 Clinical Study (GLORY-2) of Mazdutide (IBI362) Higher Dose 9 mg in Chinese Adults with Obesity

ROCKVILLE, Md. and SUZHOU, China, Jan. 1, 2024 /PRNewswire/ — Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and other major diseases, announces that the first participant has been successfully dosed…

Luxury Vehicle Condos Coming To Maine

Luxury Vehicle Condos Coming To Maine

Real estate developer Mark McClure is launching his “Luxury Motor Toys” brand in Greater Portland Maine this summer PORTLAND, Maine, Dec. 30, 2023 /PRNewswire/ — Developer Mark McClure, managing director for real estate investment firm GenX Capital Partners (http://www.GenXCP.com), is set to transform the landscape of personal…